Why the study?
The concept of hypertrophic cardiomyopathy has changed significantly with advances in cardiogenomics, sarcomeric structure, and hypertrophy-causing mutations, while phenocopies remain a major clinical diagnostic challenge.
Key points are not available for this paper at this time.
Design
Review article
This review summarizes the state of the art in the diagnosis and treatment of hypertrophic cardiomyopathy, including the role of cardiogenomics and differential diagnosis of phenocopies.
No takes yet. Share an insight, caveat, or question.
Saraiva et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: